About Programs Patients Sustainability Collaborations Investors Careers Now's the Committed to patients and their families At Assembly Bio, patients are our first priority. Through our work, we understand the challenges involved in living with illnesses like chronic hepatitis B virus (HBV) infection. That‘s why we’re focused on developing treatments that could free patients from lifelong therapy. Clinical studies We know how difficult the road ahead can sometimes seem when navigating the complexities of a disease, evaluating treatment options, and doing your best to balance everything else in life. It is the needs of patients that inspire our team to work harder and smarter to advance cures and potentially life-changing treatments. Resources “It’s time to end the deadly hepatitis B virus that has killed more than 800,000 people a year, including my own family members. Finally, it appears to be happening with increased awareness and research into new therapies. I’m especially encouraged by the efforts of Assembly Bio to develop better treatments that could lead to a cure. If they succeed, it’ll be transformational for patients, like me, whose lives are threatened by hepatitis B each day.” Infected at birth with chronic hepatitis B. Contact Us 833.509.4583 info@assemblybio.com LinkedIn About Programs Patients Sustainability Collaborations Investors Careers © 2021 Assembly Biosciences, Inc.